Pfizer CEO Albert Bourla did an interview with CNBC. Meg Tirrell asked Bourla about how they plan on attacking this new covid-19 variant omicron. Pfizer’s CEO stated his company could possibly have a vaccine for the omicron variant in less than 100 days.
“The good news when it comes to our treatment, it was designed with that in mind, it was designed with the fact that most mutations are coming in the spikes, so that gives me a very high level of confidence that the treatment will not be affected, our oral treatment will not be affected by this virus.” – Albert Bourla, Pfizer CEO
Check out the clip below.